200,000+ products from a single source!
sales@angenechem.com
Home > Nitro Compounds > 504-88-1
504-88-1 | 3-Nitropropionic acid
CAS No: 504-88-1 Catalog No: AG003JTU MDL No:MFCD00007406
Product Description
Catalog Number:
AG003JTU
Chemical Name:
3-Nitropropionic acid
CAS Number:
504-88-1
Molecular Formula:
C3H5NO4
Molecular Weight:
119.0761
MDL Number:
MFCD00007406
IUPAC Name:
3-nitropropanoic acid
InChI:
InChI=1S/C3H5NO4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)
InChI Key:
WBLZUCOIBUDNBV-UHFFFAOYSA-N
SMILES:
[O-][N+](=O)CCC(=O)O
EC Number:
208-003-0
UNII:
QY4L0FOX0D
NSC Number:
64266
UN Number:
2811
Properties
Complexity:
104
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
119.022g/mol
Formal Charge:
0
Heavy Atom Count:
8
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
119.076g/mol
Monoisotopic Mass:
119.022g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
83.1A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.5
Literature
| Title | Journal |
|---|---|
| Topiramate mitigates 3-nitropropionic acid-induced striatal neurotoxicity via modulation of AMPA receptors. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20180801 |
| Selection of antioxidants against ovarian oxidative stress in mouse model. | Journal of biochemical and molecular toxicology 20171201 |
| Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia. | PloS one 20170101 |
| A novel therapeutic application of solid lipid nanoparticles encapsulated thymoquinone (TQ-SLNs) on 3-nitroproponic acid induced Huntington's disease-like symptoms in wistar rats. | Chemico-biological interactions 20160825 |
| Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications. | Neurotoxicity research 20150101 |
| Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration. | Neurotoxicology 20141201 |
| Inhibition of Candida albicans isocitrate lyase activity by cadiolides and synoilides from the ascidian Synoicum sp. | Bioorganic & medicinal chemistry letters 20130715 |
| Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo. | Neuro-degenerative diseases 20130101 |
| Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. | Neuroscience 20121227 |
| The NMDA receptor subunit GluN3A protects against 3-nitroproprionic-induced striatal lesions via inhibition of calpain activation. | Neurobiology of disease 20121201 |
| Antibiotic susceptibility profile of Mycobacterium avium subspecies hominissuis is altered in low-iron conditions. | The Journal of antimicrobial chemotherapy 20121201 |
| Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway. | Journal of neurovirology 20121201 |
| Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. | Neurotoxicology 20121001 |
| Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues. | European journal of medicinal chemistry 20121001 |
| Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles. | European journal of medicinal chemistry 20121001 |
| 3-Nitropropionic acid modifies neurotrophin mRNA expression in the mouse striatum: 18S-rRNA is a reliable control gene for studies of the striatum. | Neuroscience bulletin 20121001 |
| Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3β in the striatum of rats treated with 3-nitropropionic acid. | Journal of neuroscience research 20120901 |
| Activating mitochondrial regulator PGC-1α expression by astrocytic NGF is a therapeutic strategy for Huntington's disease. | Neuropharmacology 20120901 |
| Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase. | Tuberculosis (Edinburgh, Scotland) 20120901 |
| Neuromodulatory propensity of Bacopa monnieri leaf extract against 3-nitropropionic acid-induced oxidative stress: in vitro and in vivo evidences. | Neurotoxicity research 20120801 |
| Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress. | The Journal of biological chemistry 20120727 |
| Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat. | Neuroscience 20120726 |
| Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. | Free radical biology & medicine 20120715 |
| Protection by glia-conditioned medium in a cell model of Huntington disease. | PLoS currents 20120702 |
| Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke. | CNS neuroscience & therapeutics 20120701 |
| Beta-carboline alkaloids derived from the ascidian Synoicum sp. | Bioorganic & medicinal chemistry 20120701 |
| Transport augmentation through the blood-inner ear barriers of guinea pigs treated with 3-nitropropionic acid and patients with acute hearing loss, visualized with 3.0 T MRI: figure labeling clarification. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20120701 |
| Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin. | The Journal of biological chemistry 20120629 |
| The dopaminergic stabilizer, (-)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins. | Brain research 20120612 |
| Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid. | Neuropathology and applied neurobiology 20120601 |
| Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage. | The ISME journal 20120601 |
| Effect of pesticides on the aggregation of mutant huntingtin protein. | Molecular neurobiology 20120601 |
| Collapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress. | Journal of neurochemistry 20120601 |
| Neuroprotective effects of extremely low-frequency electromagnetic fields on a Huntington's disease rat model: effects on neurotrophic factors and neuronal density. | Neuroscience 20120503 |
| Selective mGluR1 antagonist EMQMCM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus. | Neurotoxicity research 20120501 |
| Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model. | Neurotoxicity research 20120501 |
| Induction of thioredoxin-interacting protein is mediated by oxidative stress, calcium, and glucose after brain injury in mice. | Neurobiology of disease 20120501 |
| pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20120501 |
| c-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons. | Neurobiology of disease 20120501 |
| A novel activity for fungal nitronate monooxygenase: detoxification of the metabolic inhibitor propionate-3-nitronate. | Archives of biochemistry and biophysics 20120501 |
| Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain. | Canadian journal of physiology and pharmacology 20120501 |
| Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro. | Brain research bulletin 20120310 |
| γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. | Nature communications 20120306 |
| Modeling mitochondrial dysfunctions in the brain: from mice to men. | Journal of inherited metabolic disease 20120301 |
| Isoform-specific toxicity of Mecp2 in postmitotic neurons: suppression of neurotoxicity by FoxG1. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120222 |
| Compromised mitochondrial complex II in models of Machado-Joseph disease. | Biochimica et biophysica acta 20120201 |
| Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial. | Journal of Korean medical science 20120201 |
| Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment. | Bosnian journal of basic medical sciences 20120201 |
| Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate. | Journal of the American Chemical Society 20120118 |
| Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. | European journal of pharmacology 20120115 |
| Bioactive lipids from the sponge Spirastrella abata. | Bioorganic & medicinal chemistry letters 20120115 |
| Downregulation of miR-199a may play a role in 3-nitropropionic acid induced ischemic tolerance in rat brain. | Brain research 20120106 |
| Early alterations of brain cellular energy homeostasis in Huntington disease models. | The Journal of biological chemistry 20120106 |
| Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. | European journal of pharmacology 20120105 |
| Phytochemical characteristics, free radical scavenging activities, and neuroprotection of five medicinal plant extracts. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| Effect of activation of canonical Wnt signaling by the Wnt-3a protein on the susceptibility of PC12 cells to oxidative and apoptotic insults. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20120101 |
| Nucleic Acid-Based Therapy Approaches for Huntington's Disease. | Neurology research international 20120101 |
| N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease. | Neuro-degenerative diseases 20120101 |
| Bmi1 is down-regulated in the aging brain and displays antioxidant and protective activities in neurons. | PloS one 20120101 |
| Quinolinic Acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. | International journal of tryptophan research : IJTR 20120101 |
| Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells. | PloS one 20120101 |
| α-Mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. | PloS one 20120101 |
| N-acetylcysteine protects against apoptosis through modulation of group I metabotropic glutamate receptor activity. | PloS one 20120101 |
| Blood-brain barrier abnormalities caused by HIV-1 gp120: mechanistic and therapeutic implications. | TheScientificWorldJournal 20120101 |
| Disruption of the serotonergic system after neonatal hypoxia-ischemia in a rodent model. | Neurology research international 20120101 |
| PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO. | PPAR research 20120101 |
| Beneficial effect of (-)schisandrin B against 3-nitropropionic acid-induced cell death in PC12 cells. | BioFactors (Oxford, England) 20120101 |
| The ketogenic diet as a treatment paradigm for diverse neurological disorders. | Frontiers in pharmacology 20120101 |
| Restoration of the striatal circuitry: from developmental aspects toward clinical applications. | Frontiers in cellular neuroscience 20120101 |
| Mitochondria: redox metabolism and dysfunction. | Biochemistry research international 20120101 |
| Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface. | International journal of nanomedicine 20120101 |
| Centella asiatica (L.) Urban: From Traditional Medicine to Modern Medicine with Neuroprotective Potential. | Evidence-based complementary and alternative medicine : eCAM 20120101 |
| Schisandrin B as a hormetic agent for preventing age-related neurodegenerative diseases. | Oxidative medicine and cellular longevity 20120101 |
| The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection. | Oxidative medicine and cellular longevity 20120101 |
| Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. | PloS one 20120101 |
| Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi. | Indian journal of pharmacology 20120101 |
| DYT1 knock-in mice are not sensitized against mitochondrial complex-II inhibition. | PloS one 20120101 |
| Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. | Human molecular genetics 20111215 |
| Neuronal apoptosis in the striatum of rats treated with 3-nitropropionic acid is not triggered by cell-cycle re-entry. | Neurotoxicology 20111201 |
| Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels. | Progress in neuro-psychopharmacology & biological psychiatry 20111201 |
| Neuroprotective effect of naringin, a dietary flavonoid against 3-nitropropionic acid-induced neuronal apoptosis. | Neurochemistry international 20111201 |
| Synthesis and antimicrobial activity of brominated resorcinol dimers. | Bioorganic & medicinal chemistry letters 20111201 |
| The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats. | Neurochemistry international 20111101 |
| Functional changes in postsynaptic adenosine A(2A) receptors during early stages of a rat model of Huntington disease. | Experimental neurology 20111101 |
| Postnatal development of tyrosine hydroxylase mRNA-expressing neurons in mouse neostriatum. | The European journal of neuroscience 20111101 |
| Late-phase recovery in the cochlear lateral wall following severe degeneration by acute energy failure. | Brain research 20111024 |
| Novel protective mechanisms of antidepressants against 3-nitropropionic acid induced Huntington's-like symptoms: a comparative study. | Journal of psychopharmacology (Oxford, England) 20111001 |
| FK506 ameliorates cell death features in Huntington's disease striatal cell models. | Neurochemistry international 20111001 |
| Is neurodegenerative disease a long-latency response to early-life genotoxin exposure? | International journal of environmental research and public health 20111001 |
| Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor. | Bioorganic & medicinal chemistry letters 20110915 |
| Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults. | Nature neuroscience 20110904 |
| Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone. | British journal of pharmacology 20110901 |
| Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease. | Journal of neuroscience research 20110901 |
| Modeling synergistic drug inhibition of Mycobacterium tuberculosis growth in murine macrophages. | Molecular bioSystems 20110901 |
| Sesterterpenes from the tropical sponge Coscinoderma sp. | Journal of natural products 20110826 |
| Both stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline enantiomers protect striatal terminals against rotenone-induced suppression of dopamine release. | Neurotoxicity research 20110801 |
| Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease. | Neuropathology and applied neurobiology 20110801 |
| Protective effect of melatonin on 3-NP induced striatal interneuron injury in rats. | Neurochemistry international 20110801 |
| Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and L-carnitine. | Nutrients 20110801 |
| Hypoxia-inducible factor directs POMC gene to mediate hypothalamic glucose sensing and energy balance regulation. | PLoS biology 20110701 |
| Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter. | Human molecular genetics 20110615 |
| Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma. | Familial cancer 20110601 |
| Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence. | Neuropeptides 20110601 |
| The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders. | Experimental neurobiology 20110601 |
| Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease. | Brain research bulletin 20110530 |
| Preferential interneuron survival in the transition zone of 3-NP-induced striatal injury in rats. | Journal of neuroscience research 20110501 |
| The herbal preparation Padma® 28 protects against neurotoxicity in PC12 cells. | Phytotherapy research : PTR 20110501 |
| Neuroprotective effects of creatine. | Amino acids 20110501 |
| NR2B subunit blockade does not affect motor symptoms induced by 3-nitropropionic acid. | Neurological research 20110501 |
| Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model. | Nutritional neuroscience 20110501 |
| Scalarane sesterterpenes from the sponge Hyatella sp. | Journal of natural products 20110425 |
| Acute and long-term response of dopamine nigrostriatal synapses to a single, low-dose episode of 3-nitropropionic acid-mediated chemical hypoxia. | Synapse (New York, N.Y.) 20110401 |
| Low doses of 3-nitropropionic acid in vivo induce damage in mouse skeletal muscle. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110401 |
| Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry. | Journal of proteome research 20110401 |
| Sargachromanols as inhibitors of Na+/K+ ATPase and isocitrate lyase. | Bioorganic & medicinal chemistry letters 20110401 |
| Evolution meets disease: penetrance and functional epistasis of mitochondrial tRNA mutations. | PLoS genetics 20110401 |
| Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes. | Behavioural brain research 20110301 |
| Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells. | Current neuropharmacology 20110301 |
| Bacopa monnieri modulates endogenous cytoplasmic and mitochondrial oxidative markers in prepubertal mice brain. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20110215 |
| Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy. | Movement disorders : official journal of the Movement Disorder Society 20110215 |
| Transport augmentation through the blood-inner ear barriers of guinea pigs treated with 3-nitropropionic acid and patients with acute hearing loss, visualized with 3.0 T MRI. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20110201 |
| Frataxin participates to the hypoxia-induced response in tumors. | Cell death & disease 20110201 |
| Geometric restraint drives on- and off-pathway catalysis by the Escherichia coli menaquinol:fumarate reductase. | The Journal of biological chemistry 20110128 |
| Chemical preconditioning-induced reactive astrocytosis contributes to the reduction of post-ischemic edema through aquaporin-4 downregulation. | Experimental neurology 20110101 |
| Flexible metabolism in Metarhizium anisopliae and Beauveria bassiana: role of the glyoxylate cycle during insect pathogenesis. | Microbiology (Reading, England) 20110101 |
| Biochemical and biophysical characterization of succinate: quinone reductase from Thermus thermophilus. | Biochimica et biophysica acta 20110101 |
| Altered microRNA regulation in Huntington's disease models. | Experimental neurology 20110101 |
| Neuroprotective effect of human mesenchymal stem cells in an animal model of double toxin-induced multiple system atrophy parkinsonism. | Cell transplantation 20110101 |
| Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection. | European journal of medicinal chemistry 20110101 |
| Differential patterns of histone acetylation in inflammatory bowel diseases. | Journal of inflammation (London, England) 20110101 |
| Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation. | PloS one 20110101 |
| Isolation and characterization of a Mn(II)-oxidizing Bacillus strain from the demosponge Suberites domuncula. | Marine drugs 20110101 |
| The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. | International journal of molecular sciences 20110101 |
| The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease. | Parkinson's disease 20110101 |
| Altered dopamine and serotonin metabolism in motorically asymptomatic R6/2 mice. | PloS one 20110101 |
| Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease. | Chang Gung medical journal 20110101 |
| Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function. | ASN neuro 20110101 |
| The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease. | PloS one 20110101 |
| Antifungal activity of redox-active benzaldehydes that target cellular antioxidation. | Annals of clinical microbiology and antimicrobials 20110101 |
| Melatonin in mitochondrial dysfunction and related disorders. | International journal of Alzheimer's disease 20110101 |
| Impairment of adult hippocampal neural progenitor proliferation by methamphetamine: role for nitrotyrosination. | Molecular brain 20110101 |
| A new drug design targeting the adenosinergic system for Huntington's disease. | PloS one 20110101 |
| Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice. | Indian journal of pharmacology 20110101 |
| Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease. | Frontiers in systems neuroscience 20110101 |
| On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress. | Neurotoxicology and teratology 20110101 |
| Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. | Neurology research international 20110101 |
| Peroxisome proliferator activator receptor gamma coactivator-1alpha (PGC-1α) improves motor performance and survival in a mouse model of amyotrophic lateral sclerosis. | Molecular neurodegeneration 20110101 |
| Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. | PloS one 20110101 |
| Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. | BMC cancer 20110101 |
| A combination of compositional index and genetic algorithm for predicting transmembrane helical segments. | PloS one 20110101 |
| C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. | Molecular neurodegeneration 20110101 |
| Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models. | PloS one 20110101 |
| GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke. | Frontiers in molecular neuroscience 20110101 |
| Motor deficits and decreased striatal dopamine receptor 2 binding activity in the striatum-specific Dyt1 conditional knockout mice. | PloS one 20110101 |
| D-β-hydroxybutyrate is protective in mouse models of Huntington's disease. | PloS one 20110101 |
| Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment. | PloS one 20110101 |
| The role of manganese superoxide dismutase in inflammation defense. | Enzyme research 20110101 |
| Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. | International journal of nanomedicine 20110101 |
| Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. | PloS one 20110101 |
| Huntington's Disease and Striatal Signaling. | Frontiers in neuroanatomy 20110101 |
| Anti-neuroinflammatory effects of the extract of Achillea fragrantissima. | BMC complementary and alternative medicine 20110101 |
| Manganese superoxide dismutase: guardian of the powerhouse. | International journal of molecular sciences 20110101 |
| Both pre- and postsynaptic activity of Nsf prevents degeneration of hair-cell synapses. | PloS one 20110101 |
| The promise of neuroprotective agents in Parkinson's disease. | Frontiers in neurology 20110101 |
| Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia. | International journal of molecular sciences 20110101 |
| Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. | Oxidative medicine and cellular longevity 20110101 |
| System-level strategies for studying the metabolism of Mycobacterium tuberculosis. | Molecular bioSystems 20101208 |
| Calcium signalling-dependent mitochondrial dysfunction and bioenergetics regulation in respiratory chain Complex II deficiency. | Cell death and differentiation 20101201 |
| Metabolic activity of the subthalamic nucleus in a primate model of L-dopa-unresponsive parkinsonism. | Neurological research 20101201 |
| Pyruvate carboxylation in different model systems studied by (13)C MRS. | Neurochemical research 20101201 |
| Protective effects of TRH and its analogues against various cytotoxic agents in retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. | Neuropeptides 20101201 |
| Synthetic analogs of indole-containing natural products as inhibitors of sortase A and isocitrate lyase. | Bioorganic & medicinal chemistry letters 20101201 |
| Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli. | EMBO molecular medicine 20101201 |
| Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning. | International neurourology journal 20101201 |
| Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway. | The Journal of biological chemistry 20101126 |
| Bromophenols as Candida albicans isocitrate lyase inhibitors. | Bioorganic & medicinal chemistry letters 20101115 |
| Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. | Neurochemistry international 20101101 |
| Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain. | Drug and chemical toxicology 20101001 |
| Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition. | Neurobiology of disease 20101001 |
| Brain region specificity of 3-nitropropionic acid-induced vulnerability of neurons involves cytochrome c oxidase. | Neurochemistry international 20101001 |
| Kainic acid and 3-Nitropropionic acid induced expression of laminin in vascular elements of the rat brain. | Brain research 20100917 |
| Androgens selectively protect against apoptosis in hippocampal neurones. | Journal of neuroendocrinology 20100901 |
| Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease. | EMBO molecular medicine 20100901 |
| The ASK1-Signalosome regulates p38 MAPK activity in response to levels of endogenous oxidative stress in the Klotho mouse models of aging. | Aging 20100901 |
| The role of mitochondria in brain aging and the effects of melatonin. | Current neuropharmacology 20100901 |
| Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol. | Neuroscience letters 20100816 |
| Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model. | Hippocampus 20100801 |
| Complex I: inhibitors, inhibition and neurodegeneration. | Experimental neurology 20100801 |
| Delayed pre-conditioning by 3-nitropropionic acid prevents 3,4-methylenedioxymetamphetamine-induced 5-HT deficits. | Journal of neurochemistry 20100801 |
| 5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures. | Bioorganic & medicinal chemistry letters 20100801 |
| Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage. | Aging 20100801 |
| Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats. | Basic & clinical pharmacology & toxicology 20100701 |
| Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration. | Journal of neuroscience research 20100701 |
| Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. | Journal of neurochemistry 20100701 |
| Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. | Experimental neurology 20100701 |
| Mechanisms underlying striatal vulnerability to 3-nitropropionic acid. | Journal of neurochemistry 20100701 |
| Brain region-specific vulnerability of astrocytes in response to 3-nitropropionic acid is mediated by cytochrome c oxidase isoform expression. | Cell and tissue research 20100701 |
| Neuroprotective mechanisms of brain-derived neurotrophic factor against 3-nitropropionic acid toxicity: therapeutic implications for Huntington's disease. | Annals of the New York Academy of Sciences 20100701 |
| Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. | Cell death & disease 20100701 |
| Prophylaxis with Centella asiatica confers protection to prepubertal mice against 3-nitropropionic-acid-induced oxidative stress in brain. | Phytotherapy research : PTR 20100601 |
| FoxO1 is involved in the antineoplastic effect of calorie restriction. | Aging cell 20100601 |
| Geranylgeranylacetone ameliorates acute cochlear damage caused by 3-nitropropionic acid. | Neurotoxicology 20100601 |
| Mitochondrial matters of the brain: the role in Huntington's disease. | Journal of bioenergetics and biomembranes 20100601 |
| Dysregulation of CREB activation and histone acetylation in 3-nitropropionic acid-treated cortical neurons: prevention by BDNF and NGF. | Neurotoxicity research 20100501 |
| Balance dysfunction resulting from acute inner ear energy failure is caused primarily by vestibular hair cell damage. | Journal of neuroscience research 20100501 |
| Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. | Neurobiology of disease 20100501 |
| Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease. | Behavioural pharmacology 20100501 |
| Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy. | Neuroreport 20100421 |
| Opening of the mitoKATP channel and decoupling of mitochondrial complex II and III contribute to the suppression of myocardial reperfusion hyperoxygenation. | Molecular and cellular biochemistry 20100401 |
| Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. | Experimental neurology 20100401 |
| Hypoxia sensing in the fetal chicken femoral artery is mediated by the mitochondrial electron transport chain. | American journal of physiology. Regulatory, integrative and comparative physiology 20100401 |
| Mitochondrial quality control and neurological disease: an emerging connection. | Expert reviews in molecular medicine 20100401 |
| HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease. | Antioxidants & redox signaling 20100215 |
| 3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions. | Journal of neuroscience research 20100215 |
| 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. | Molecules (Basel, Switzerland) 20100210 |
| Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes. | Neurochemistry international 20100201 |
| Enhanced expression of C/EBP homologous protein (CHOP) precedes degeneration of fibrocytes in the lateral wall after acute cochlear mitochondrial dysfunction induced by 3-nitropropionic acid. | Neurochemistry international 20100201 |
| Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. | Behavioural brain research 20100105 |
| Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats. | Neurotoxicology and teratology 20100101 |
| Protective effect of tert-butylhydroquinone on the quinolinic-acid-induced toxicity in rat striatal slices: role of the Nrf2-antioxidant response element pathway. | Neuro-Signals 20100101 |
| Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats. | Neurochemistry international 20100101 |
| Promethazine protects against 3-nitropropionic acid-induced neurotoxicity. | Neurochemistry international 20100101 |
| Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. | The Journal of biological chemistry 20100101 |
| Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine. | Journal of neural transmission (Vienna, Austria : 1996) 20100101 |
| Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. | Experimental neurology 20100101 |
| Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review. | Lipids in health and disease 20100101 |
| Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease. | Journal of neuroinflammation 20100101 |
| Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. | Experimental & translational stroke medicine 20100101 |
| Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition. | Neurochemistry international 20100101 |
| Comprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocycline. | PloS one 20100101 |
| Genetic mouse models of Huntington's disease: focus on electrophysiological mechanisms. | ASN neuro 20100101 |
| The bright and the dark sides of DNA repair in stem cells. | Journal of biomedicine & biotechnology 20100101 |
| Uncoupling oxidative/energy metabolism with low sub chronic doses of 3-nitropropionic acid or iodoacetate in vivo produces striatal cell damage. | International journal of biological sciences 20100101 |
| Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism. | International journal of toxicology 20100101 |
| Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease. | ASN neuro 20100101 |
| Oxidative stress induced in rat brain by a combination of 3-nitropropionic acid and global ischemia. | International journal of clinical and experimental medicine 20100101 |
| Effects of mitochondrial dysfunction on the immunological properties of microglia. | Journal of neuroinflammation 20100101 |
| Mitochondrial preconditioning: a potential neuroprotective strategy. | Frontiers in aging neuroscience 20100101 |
| PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. | Cell communication and signaling : CCS 20100101 |
| Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder. | International journal of tryptophan research : IJTR 20100101 |
| An investigation of the neuroprotective effects of Curcumin in a model of Homocysteine - induced oxidative stress in the rat's brain. | Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101 |
| Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. | Journal of neurology 20091201 |
| Down-regulation of Bcl-2 enhances autophagy activation and cell death induced by mitochondrial dysfunction in rat striatum. | Journal of neuroscience research 20091201 |
| Protective effects of epigallocatechin gallate following 3-nitropropionic acid-induced brain damage: possible nitric oxide mechanisms. | Psychopharmacology 20091201 |
| Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: possible glutamatergic and dopaminergic involvement. | Acta biologica Hungarica 20091201 |
| Cyclopiazonic acid biosynthesis of Aspergillus flavus and Aspergillus oryzae. | Toxins 20091201 |
| Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. | Life sciences 20091104 |
| Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes. | Glia 20091101 |
| Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats. | Neurochemistry international 20091101 |
| CREB is a key regulator of striatal vulnerability in chemical and genetic models of Huntington's disease. | Neurobiology of disease 20091101 |
| Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins. | Neurobiology of disease 20091101 |
| An anaerobic-type alpha-ketoglutarate ferredoxin oxidoreductase completes the oxidative tricarboxylic acid cycle of Mycobacterium tuberculosis. | PLoS pathogens 20091101 |
| Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment. | Neuroscience 20091020 |
| Preconditioning with 4-aminopyridine protects cerebellar granule neurons against excitotoxicity. | Brain research 20091019 |
| Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases. | Human molecular genetics 20091015 |
| Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20091001 |
| Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. | The Journal of comparative neurology 20091001 |
| Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid. | Journal of neurochemistry 20091001 |
| Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons. | Journal of neurochemistry 20091001 |
| ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20090901 |
| Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy. | Journal of neuroscience research 20090901 |
| BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons. | Neurobiology of disease 20090901 |
| Involvement of nitric oxide in 3-nitropropionic acid-induced depression of spinal reflexes in neonatal rat spinal cord in vitro. | European journal of pharmacology 20090901 |
| Anaerobic central metabolic pathways active during polyhydroxyalkanoate production in uncultured cluster 1 Defluviicoccus enriched in activated sludge communities. | FEMS microbiology letters 20090901 |
| Induction of membrane permeability in Escherichia coli mediated by lysis protein of the ColE7 operon. | FEMS microbiology letters 20090901 |
| Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain. | Indian journal of experimental biology 20090901 |
| Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma. | Journal of physiology and biochemistry 20090901 |
| Dermal fibroblasts from long-lived Ames dwarf mice maintain their in vivo resistance to mitochondrial generated reactive oxygen species (ROS). | Aging 20090901 |
| Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity. | Current neuropharmacology 20090901 |
| In vitro antioxidant activity of Valeriana officinalis against different neurotoxic agents. | Neurochemical research 20090801 |
| Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations. | European journal of pharmacology 20090801 |
| Early nerve ending rescue from oxidative damage and energy failure by L: -carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities. | Experimental brain research 20090801 |
| Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acid. | Biochemical and biophysical research communications 20090717 |
| In vivo dopamine release and uptake impairments in rats treated with 3-nitropropionic acid. | Neuroscience 20090707 |
| Metabonomic characterization of the 3-nitropropionic acid rat model of Huntington's disease. | Neurochemical research 20090701 |
| Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons. | Neurotoxicology 20090701 |
| The brain uncoupling protein UCP4 attenuates mitochondrial toxin-induced cell death: role of extracellular signal-regulated kinases in bioenergetics adaptation and cell survival. | Neurotoxicity research 20090701 |
| Heme oxygenase-1 induction prevents neuronal damage triggered during mitochondrial inhibition: role of CO and bilirubin. | The international journal of biochemistry & cell biology 20090601 |
| A mouse model for degeneration of the spiral ligament. | Journal of the Association for Research in Otolaryngology : JARO 20090601 |
| Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. | Cell death and differentiation 20090601 |
| Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid. | International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 20090601 |
| Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases. | Journal of neurochemistry 20090601 |
| Site-directed mutagenesis, kinetic and inhibition studies of aspartate ammonia lyase from Bacillus sp. YM55-1. | The FEBS journal 20090601 |
| Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. | Journal of medicinal food 20090601 |
| Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. | Behavioural brain research 20090516 |
| Antioxidant effects of different extracts from Melissa officinalis, Matricaria recutita and Cymbopogon citratus. | Neurochemical research 20090501 |
| Effects of nitrocompounds on uric acid-utilizing microorganisms, nitrogen retention, and microbial community in laying hen manure. | Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20090501 |
| GABAergic striatal neurons exhibit caspase-independent, mitochondrially mediated programmed cell death. | Journal of neurochemistry 20090501 |
| Mitochondria and energetic depression in cell pathophysiology. | International journal of molecular sciences 20090501 |
| No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication. | Neuroscience bulletin 20090401 |
| Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. | Brain : a journal of neurology 20090401 |
| p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum. | Autophagy 20090401 |
| [Model of Huntington's disease induced with 3-nitropropionic acid]. | Revista de neurologia 20090401 |
| Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide. | Neuroscience research 20090401 |
| N-methyl-D-aspartate receptor antagonists have variable affect in 3-nitropropionic acid toxicity. | Neurochemical research 20090301 |
| Targeting the progression of Parkinson's disease. | Current neuropharmacology 20090301 |
| 5-Hydroxyindole-type alkaloids, as Candida albicans isocitrate lyase inhibitors, from the tropical sponge Hyrtios sp. | Bioorganic & medicinal chemistry letters 20090215 |
| Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro. | Neuropharmacology 20090201 |
| Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease. | Diabetes 20090201 |
| Impaired mitochondria-dependent vasodilation in cerebral arteries of Zucker obese rats with insulin resistance. | American journal of physiology. Regulatory, integrative and comparative physiology 20090201 |
| Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. | Progress in neuro-psychopharmacology & biological psychiatry 20090201 |
| The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue. | Nutritional neuroscience 20090201 |
| Mitochondrial dysfunction disrupts trafficking of Kir4.1 in spiral ganglion satellite cells. | Journal of neuroscience research 20090101 |
| Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid. | Pharmacology, biochemistry, and behavior 20090101 |
| Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease. | DNA repair 20090101 |
| Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes. | Journal of molecular and cellular cardiology 20090101 |
| Blood-brain barrier disruption in the striatum of rats treated with 3-nitropropionic acid. | Neurotoxicology 20090101 |
| Normal aging modulates the neurotoxicity of mutant huntingtin. | PloS one 20090101 |
| Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy. | BMC neuroscience 20090101 |
| Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. | PloS one 20090101 |
| IKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin. | PloS one 20090101 |
| Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity. | PloS one 20090101 |
| Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. | Journal of Asian natural products research 20090101 |
| A systems biology framework for modeling metabolic enzyme inhibition of Mycobacterium tuberculosis. | BMC systems biology 20090101 |
| Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. | Molecular brain 20090101 |
| Does neuroinflammation fan the flame in neurodegenerative diseases? | Molecular neurodegeneration 20090101 |
| Coenzyme Q10 effects in neurodegenerative disease. | Neuropsychiatric disease and treatment 20090101 |
| Dopamine D2 receptor stimulation potentiates PolyQ-Huntingtin-induced mouse striatal neuron dysfunctions via Rho/ROCK-II activation. | PloS one 20090101 |
| Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. | Neuron 20081226 |
| Galantamine reduces striatal degeneration in 3-nitropropionic acid model of Huntington's disease. | Neuroscience letters 20081219 |
| 3-Nitropropionic acid-induced depression of spinal reflexes involves mechanisms different from ischemia-induced depression. | Brain research bulletin 20081216 |
| Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress. | Neuroscience letters 20081212 |
| 3-Nitropropionic acid-induced depression of spinal reflexes does not involve 5-hydroxytryptaminergic system in contrast to ischemia-induced depression in neonatal rat spinal cord in vitro. | Neuroscience letters 20081203 |
| Bcl-2 upregulation after 3-nitropropionic acid preconditioning in warm rat liver ischemia. | Shock (Augusta, Ga.) 20081201 |
| Effects of select nitrocompounds on in vitro ruminal fermentation during conditions of limiting or excess added reductant. | Bioresource technology 20081201 |
| Mechanism of 3-nitropropionic acid-induced membrane permeability transition of isolated mitochondria and its suppression by L-carnitine. | Cell biochemistry and function 20081201 |
| Modulation of alpha-synuclein expression in transgenic animals for modelling synucleinopathies--is the juice worth the squeeze? | Neurotoxicity research 20081201 |
| 3-Nitropropionic acid depresses spinal reflexes involving GABAergic and glycinergic transmission in neonatal rat spinal cord in vitro. | Life sciences 20081121 |
| Effect of Centella asiatica leaf powder on oxidative markers in brain regions of prepubertal mice in vivo and its in vitro efficacy to ameliorate 3-NPA-induced oxidative stress in mitochondria. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20081101 |
| Cell cycle activation in striatal neurons from Huntington's disease patients and rats treated with 3-nitropropionic acid. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20081101 |
| Neurotoxicological effects of 3-nitropropionic acid on the neonatal rat. | Neurotoxicology 20081101 |
| Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. | Neurotoxicology 20081101 |
| Scalarane sesterterpenes from the sponge Smenospongia sp. | Journal of natural products 20081101 |
| A role for oxidized DNA precursors in Huntington's disease-like striatal neurodegeneration. | PLoS genetics 20081101 |
| A pharmacological MRI assessment of dizocilpine (MK-801) in the 3-nitroproprionic acid-lesioned rat. | Neuroscience letters 20081017 |
| Inhibition of Candida albicans isocitrate lyase activity by sesterterpene sulfates from the tropical sponge Dysidea sp. | Bioorganic & medicinal chemistry letters 20081015 |
| Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice. | The FEBS journal 20081001 |
| The mechanism of the late preconditioning effect of 3-nitropropionic acid. | Archives of pharmacal research 20081001 |
| Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine. | Free radical research 20081001 |
| Brain adaptation to stressful stimuli: a new perspective on potential therapeutic approaches based on BDNF and NMDA receptors. | CNS & neurological disorders drug targets 20081001 |
| Miscellaneous. | Indian journal of pharmacology 20081001 |
| Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20080917 |
| Melatonin combats molecular terrorism at the mitochondrial level. | Interdisciplinary toxicology 20080901 |
| Preconditioning with NMDA protects against toxicity of 3-nitropropionic acid or glutamate in cultured cerebellar granule neurons. | Neuroscience letters 20080808 |
| Depressive-like behavior in mice recently recovered from motor disorders after 3-nitropropionic acid intoxication. | Neuroscience bulletin 20080801 |
| Current approaches to the treatment of Parkinson's disease. | Neuropsychiatric disease and treatment 20080801 |
| Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. | Neuroscience 20080717 |
| Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. | Brain research 20080618 |
| Responses of differentiated MC3T3-E1 osteoblast-like cells to reactive oxygen species. | European journal of pharmacology 20080610 |
| Chemical hypoxia facilitates alternative splicing of EAAT2 in presymptomatic APP23 transgenic mice. | Neurochemical research 20080601 |
| Neuroprotection of lamotrigine on hypoxic-ischemic brain damage in neonatal rats: Relations to administration time and doses. | Biologics : targets & therapy 20080601 |
| Altered striatal vulnerability to 3-nitropropionic acid in rats due to sex hormone levels during late phase of brain development. | Neuroscience letters 20080516 |
| Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II. | Human molecular genetics 20080515 |
| Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine. | Journal of neurochemistry 20080501 |
| Sensory motor mismatch within the supplementary motor area in the dystonic monkey. | Neurobiology of disease 20080501 |
| Chemical preconditioning effect of 3-nitropropionic acid in anesthetized rat heart. | Life sciences 20080423 |
| NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease. | Neuroscience letters 20080404 |
| Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. | Experimental neurology 20080401 |
| Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20080401 |
| Developmental exposure to polychlorinated biphenyls influences stroke outcome in adult rats. | Environmental health perspectives 20080401 |
| Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats. | Neuropsychiatric disease and treatment 20080401 |
| Application of multipotent mesenchymal stromal cells from human adipose tissue for compensation of neurological deficiency induced by 3-nitropropionic Acid in rats. | Bulletin of experimental biology and medicine 20080401 |
| Differential involvement of cell cycle reactivation between striatal and cortical neurons in cell death induced by 3-nitropropionic acid. | The Journal of biological chemistry 20080307 |
| Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways. | Journal of neurochemistry 20080301 |
| Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. | Psychopharmacology 20080301 |
| Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. | Neurotoxicology 20080301 |
| Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats. | The European journal of neuroscience 20080301 |
| Preconditioning paradigms and pathways in the brain. | Cleveland Clinic journal of medicine 20080301 |
| Regional susceptibility to domoic acid in primary astrocyte cells cultured from the brain stem and hippocampus. | Marine drugs 20080301 |
| Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. | Toxicology 20080227 |
| Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease. | Brain research 20080215 |
| The impact of mitochondrial energetic dysfunction on apoptosis in outer hair cells of the cochlea following exposure to intense noise. | Hearing research 20080201 |
| Induction of apoptosis signal-regulating kinase 1 and oxidative stress mediate age-dependent vulnerability to 3-nitropropionic acid in the mouse striatum. | Neuroscience letters 20080110 |
| Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction. | Journal of neuroscience research 20080101 |
| Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease. | Journal of neurochemistry 20080101 |
| Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression. | Stem cells (Dayton, Ohio) 20080101 |
| Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. | Journal of neuroinflammation 20080101 |
| Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation. | PloS one 20080101 |
| Proteomic modeling for HIV-1 infected microglia-astrocyte crosstalk. | PloS one 20080101 |
| Ototoxic interaction of kanamycin and 3-nitropropionic acid. | Acta oto-laryngologica 20080101 |
| PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. | PloS one 20080101 |
| Protective efficiacy of taurine against pulmonary edema progression: experimental study. | Journal of cardiothoracic surgery 20080101 |
| Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats. | Pharmacological reports : PR 20080101 |
| Reaction of chromium(III) with 3,4-dihydroxybenzoic acid: kinetics and mechanism in weak acidic aqueous solutions. | Bioinorganic chemistry and applications 20080101 |
| Inflammatory and neurochemical changes associated with 3-nitropropionic Acid neurotoxicity. | Toxicology mechanisms and methods 20080101 |
| Citicoline is not protective in experimental models of Huntington's disease. | Neurobiology of aging 20071201 |
| Catecholamine exocytosis is diminished in R6/2 Huntington's disease model mice. | Journal of neurochemistry 20071201 |
| Neurotoxic effects of repetitive inhibition of oxidative phosphorylation in young adults surfacing with deficits of spatial learning in old age. | The journals of gerontology. Series A, Biological sciences and medical sciences 20071201 |
| Cannabinoids in health and disease. | Dialogues in clinical neuroscience 20071201 |
| IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. | Neuroscience letters 20071002 |
| Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. | Experimental neurology 20071001 |
| Commonly used tropical medicinal plants exhibit distinct in vitro antioxidant activities against hepatotoxins in rat liver. | Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20070801 |
| Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina. | Experimental brain research 20070801 |
| The role of mitochondria in protection of the heart by preconditioning. | Biochimica et biophysica acta 20070801 |
| Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. | The European journal of neuroscience 20070801 |
| Co-localization and functional cross-talk between A1 and P2Y1 purine receptors in rat hippocampus. | The European journal of neuroscience 20070801 |
| Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism. | PLoS genetics 20070801 |
| Changes in opioid receptor proteins during mitochondrial impairment in differentiated SK-N-SH cells. | Neuroscience letters 20070718 |
| Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20070718 |
| Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord. | Journal of neuroscience research 20070701 |
| Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. | The American journal of pathology 20070701 |
| 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum. | Neuroscience letters 20070621 |
| Exacerbation of excitotoxic neuronal death induced during mitochondrial inhibition in vivo: relation to energy imbalance or ATP depletion? | Neuroscience 20070608 |
| Ubiquitin-proteasome system alterations in a striatal cell model of Huntington's disease. | Journal of neuroscience research 20070601 |
| Manganese targets m-aconitase and activates iron regulatory protein 2 in AF5 GABAergic cells. | Journal of neuroscience research 20070601 |
| Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. | Fundamental & clinical pharmacology 20070601 |
| Mutant SOD1G93A in bone marrow-derived cells exacerbates 3-nitropropionic acid induced striatal damage in mice. | Neuroscience letters 20070517 |
| Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease. | Neurobiology of disease 20070501 |
| Effect of testosterone on oxidative stress and cell damage induced by 3-nitropropionic acid in striatum of ovariectomized rats. | Life sciences 20070306 |
| Gender- and region-specific expression of insulin receptor protein in mouse brain: effect of mild inhibition of oxidative phosphorylation. | Journal of neural transmission (Vienna, Austria : 1996) 20070301 |
| Cerebellar granule neurons are more vulnerable to transient transport-mediated glutamate release than to glutamate uptake blockade. correlation with excitatory amino acids levels. | Neurochemical research 20070301 |
| Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. | Progress in neuro-psychopharmacology & biological psychiatry 20070130 |
| Pharmacological MRI of stem cell transplants in the 3-nitropropionic acid-damaged striatum. | Neuroscience 20070105 |
| Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders. | Journal of neurochemistry 20070101 |
| Mitochondrial toxins and neurodegenerative diseases. | Frontiers in bioscience : a journal and virtual library 20070101 |
| Integrative hypothesis for Huntington's disease: a brief review of experimental evidence. | Physiological research 20070101 |
| Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. | Mitochondrion 20070101 |
| Proteasome activator enhances survival of Huntington's disease neuronal model cells. | PloS one 20070101 |
| Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. | Methods and findings in experimental and clinical pharmacology 20070101 |
| Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHA. | BMC biology 20070101 |
| Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. | PloS one 20070101 |
| Hyperglycemia enhances the inhibitory effect of mitochondrial toxins and D,L-homocysteine on the brain production of kynurenic acid. | Pharmacological reports : PR 20070101 |
| Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. | PloS one 20070101 |
| Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. | BMC infectious diseases 20070101 |
| The responses of HT22 cells to the blockade of mitochondrial complexes and potential protective effect of selenium supplementation. | International journal of biological sciences 20070101 |
| Animal models of Huntington's disease. | ILAR journal 20070101 |
| The functional genome of CA1 and CA3 neurons under native conditions and in response to ischemia. | BMC genomics 20070101 |
| Developmental stage of oligodendrocytes determines their response to activated microglia in vitro. | Journal of neuroinflammation 20070101 |
| Polyphasic taxonomy of Aspergillus section Candidi based on molecular, morphological and physiological data. | Studies in mycology 20070101 |
| MEK inhibition exacerbates ischemic calcium imbalance and neuronal cell death in rat cortical cultures. | European journal of pharmacology 20061228 |
| Co-regulation of dopamine D1 receptor and uncoupling protein-2 expression in 3-nitropropionic acid-induced neurotoxicity: neuroprotective role of L-carnitine. | Neuroscience letters 20061213 |
| Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease. | Neuroscience letters 20061213 |
| NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum. | Experimental neurology 20061201 |
| Acute administration of 3-nitropropionic acid, a reactive oxygen species generator, boosts ethanol-induced locomotor stimulation. New support for the role of brain catalase in the behavioural effects of ethanol. | Neuropharmacology 20061201 |
| Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. | Neurobiology of disease 20061201 |
| Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease. | Brain research 20061106 |
| D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease. | Journal of neuroscience research 20061101 |
| Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. | Cell metabolism 20061101 |
| Adenosine A2A receptors in bone marrow-derived cells but not in forebrain neurons are important contributors to 3-nitropropionic acid-induced striatal damage as revealed by cell-type-selective inactivation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20061101 |
| Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity. | Journal of inherited metabolic disease 20061001 |
| Localization of superoxide anion production to mitochondrial electron transport chain in 3-NPA-treated cells. | Mitochondrion 20061001 |
| Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats. | Brain research 20060907 |
| Increased 'vigilance' of antioxidant mechanisms in neural stem cells potentiates their capability to resist oxidative stress. | Stem cells (Dayton, Ohio) 20060901 |
| S-Allylcysteine prevents the rat from 3-nitropropionic acid-induced hyperactivity, early markers of oxidative stress and mitochondrial dysfunction. | Neuroscience research 20060901 |
| Effect of transcranial magnetic stimulation on oxidative stress induced by 3-nitropropionic acid in cortical synaptosomes. | Neuroscience research 20060901 |
| Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. | Behavioural pharmacology 20060901 |
| Differential effects of impaired mitochondrial energy production on the function of mu and delta opioid receptors in neuronal SK-N-SH cells. | Neuroscience letters 20060814 |
| Effects of L-carnitine pretreatment in methamphetamine and 3-nitropropionic acid-induced neurotoxicity. | Annals of the New York Academy of Sciences 20060801 |
| The stamp of ancestry: roots of behavioral and neuronal impairment in adulthood. | Experimental neurology 20060701 |
| Analysis of the regulation, expression, and localisation of the isocitrate lyase from Aspergillus fumigatus, a potential target for antifungal drug development. | Fungal genetics and biology : FG & B 20060701 |
| Mitochondrial inhibition prior to oxygen-withdrawal facilitates the occurrence of hypoxia-induced spreading depression in rat hippocampal slices. | Journal of neurophysiology 20060701 |
| Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity. | Journal of neuroscience research 20060701 |
| Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060701 |
| Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. | The Journal of biological chemistry 20060616 |
| Longevity in mice: is stress resistance a common factor? | Age (Dordrecht, Netherlands) 20060601 |
| Caspase-dependent and -independent cell death induced by 3-nitropropionic acid in rat cortical neurons. | Journal of cellular biochemistry 20060501 |
| The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts. | Cardiovascular research 20060501 |
| Transcranial magnetic stimulation attenuates cell loss and oxidative damage in the striatum induced in the 3-nitropropionic model of Huntington's disease. | Journal of neurochemistry 20060501 |
| Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+ entry during NMDA receptor activation. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060501 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity. | The European journal of neuroscience 20060501 |
| Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons. | Neurobiology of disease 20060401 |
| 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats. | Neurochemistry international 20060401 |
| Endotoxin preconditioning protects neurones from in vitro ischemia: role of endogenous IL-1beta and TNF-alpha. | Journal of neuroimmunology 20060401 |
| Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells. | The European journal of neuroscience 20060401 |
| [The research of the pathogen responsible for Pleurocybella porrigens related encephalopathy: investigation of 3-nitropropionic acid hypothesis]. | No to shinkei = Brain and nerve 20060401 |
| Lactate dehydrogenase activity is inhibited by methylmalonate in vitro. | Neurochemical research 20060401 |
| 3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. | The Journal of biological chemistry 20060303 |
| Mice lacking alpha-synuclein are resistant to mitochondrial toxins. | Neurobiology of disease 20060301 |
| Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. | Hepatology (Baltimore, Md.) 20060301 |
| Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools. | Biochemical pharmacology 20060214 |
| Mechanisms of hypoxic tolerance in presymptomatic APP23 transgenic mice. | Mechanisms of ageing and development 20060201 |
| [Aristolochic acid nephropathy and acute encephalopathy related to Pleurocybella porrigens (Sugihiratake)]. | Nihon rinsho. Japanese journal of clinical medicine 20060201 |
| Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. | Brain research bulletin 20060130 |
| Alterations in the cortical and peripheral somatosensory evoked activity of rats treated with 3-nitropropionic acid. | Toxicology letters 20060125 |
| UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101 |
| Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease. | Neurochemistry international 20060101 |
| Growth inhibition by nitrocompounds of selected uric acid-utilizing microorganisms isolated from poultry manure. | Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes 20060101 |
| The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. | BMC cancer 20060101 |
| Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease. | Neuroscience 20060101 |
| [Hairy root induction and plant regeneration of crownvetch (Coronilla varia L.) transformed by Agrobacterium rhizogenes]. | Sheng wu gong cheng xue bao = Chinese journal of biotechnology 20060101 |
| Delayed postconditionig initiates additive mechanism necessary for survival of selectively vulnerable neurons after transient ischemia in rat brain. | Cellular and molecular neurobiology 20060101 |
| Melatonin in Alzheimer's disease and other neurodegenerative disorders. | Behavioral and brain functions : BBF 20060101 |
| The changes in endogenous antioxidant enzyme activity after postconditioning. | Cellular and molecular neurobiology 20060101 |
| Hypoxic vasoconstriction of partial muscular intra-acinar pulmonary arteries in murine precision cut lung slices. | Respiratory research 20060101 |
| Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets. | Theoretical biology & medical modelling 20060101 |
| 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism. | Hippocampus 20060101 |
| Involvement of calpain activation in neurodegenerative processes. | CNS drug reviews 20060101 |
| Genetic analysis of the GRIK2 modifier effect in Huntington's disease. | BMC neuroscience 20060101 |
| Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics. | Journal of biomedicine & biotechnology 20060101 |
| Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. | BMC neuroscience 20060101 |
| Cerebral ischemic tolerance induced by 3-nitropropionic acid is associated with increased expression of erythropoietin in rats. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101 |
| The acute effects of 3-nitropropionic acid on the behavior and spontaneous cortical electrical activity of rats. | Acta neurobiologiae experimentalis 20060101 |
| Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. | BMC neuroscience 20060101 |
| Inhibition of mitochondrial complex II affects dopamine metabolism and decreases its uptake into striatal synaptosomes. | Folia neuropathologica 20060101 |
| Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies. | Current neuropharmacology 20060101 |
| Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival. | The Journal of biological chemistry 20051209 |
| 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. | Journal of neurochemistry 20051201 |
| Effects of 3-nitropropionic acid in rats: general toxicity and functional neurotoxicity. | Arhiv za higijenu rada i toksikologiju 20051201 |
| Neuroprotective effect of taurine in 3-nitropropionic acid-induced experimental animal model of Huntington's disease phenotype. | Pharmacology, biochemistry, and behavior 20051101 |
| Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region. | Neurochemical research 20051101 |
| Effects of mitochondrial toxins on the brain amino acid concentrations. | Neurochemical research 20051101 |
| Behavioral alterations in Lewis rats following two-day continuous 3-nitropropionic acid administration. | Neurotoxicity research 20051101 |
| Differential effects of sublethal ischemia and chemical preconditioning with 3-nitropropionic acid on protein expression in gerbil hippocampus. | Life sciences 20051021 |
| The histaminergic signaling system exerts a neuroprotective role against neurodegenerative-induced processes in the hamster. | The Journal of pharmacology and experimental therapeutics 20051001 |
| Neuroprotective effect of zVAD against the neurotoxin 3-nitropropionic acid involves inhibition of calpain. | Neuropharmacology 20051001 |
| Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. | Journal of neurochemistry 20051001 |
| [Animal models of parkinsonism]. | Revue neurologique 20051001 |
| Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats. | Brain research bulletin 20050930 |
| A potential role for beta- and gamma-crystallins in the vascular remodeling of the eye. | Developmental dynamics : an official publication of the American Association of Anatomists 20050901 |
| Depressant effect of mitochondrial respiratory complex inhibitors on proteasome inhibitor-induced mitochondrial dysfunction and cell death in PC12 cells. | Neurochemical research 20050901 |
| Mitochondrial regulation of insulin production in rat pancreatic islets. | Diabetologia 20050801 |
| Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. | Journal of neurochemistry 20050801 |
| Identification of rat hippocampal mRNAs altered by the mitochondrial toxicant, 3-NPA. | Annals of the New York Academy of Sciences 20050801 |
| L-carnitine and neuroprotection in the animal model of mitochondrial dysfunction. | Annals of the New York Academy of Sciences 20050801 |
| Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. | Annals of the New York Academy of Sciences 20050801 |
| Effects of ATP-sensitive potassium channel activators diazoxide and BMS-191095 on membrane potential and reactive oxygen species production in isolated piglet mitochondria. | Brain research bulletin 20050730 |
| The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat. | Brain research 20050719 |
| Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease. | Brain research 20050719 |
| Crystal structure of mitochondrial respiratory membrane protein complex II. | Cell 20050701 |
| Inducible neuronal expression of transgenic TGF-beta1 in vivo: dissection of short-term and long-term effects. | The European journal of neuroscience 20050701 |
| 3-Nitropropionic acid (3-NPA), a potent antimycobacterial agent from endophytic fungi: is 3-NPA in some plants produced by endophytes? | Journal of natural products 20050701 |
| The differential JunB responses to inhibition of succinate dehydrogenase in rat hippocampus and liver. | Neuroscience letters 20050624 |
| Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease. | Brain research 20050621 |
| Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. | The Journal of biological chemistry 20050617 |
| Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. | Brain research 20050607 |
| Treatment with dehydroepiandrosterone prevents oxidative stress induced by 3-nitropropionic acid in synaptosomes. | Pharmacology 20050601 |
| Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. | Nature medicine 20050601 |
| Neuroprotection by adenosine in the brain: From A(1) receptor activation to A (2A) receptor blockade. | Purinergic signalling 20050601 |
| The nature of the stimulus and of the fumarate binding site of the fumarate sensor DcuS of Escherichia coli. | The Journal of biological chemistry 20050527 |
| Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice. | Journal of neural transmission (Vienna, Austria : 1996) 20050501 |
| Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. | Journal of neurochemistry 20050501 |
| Protective effects of ginseng components in a rodent model of neurodegeneration. | Annals of neurology 20050501 |
| Grafted neural stem cells shield the host environment from oxidative stress. | Annals of the New York Academy of Sciences 20050501 |
| Functional neurotoxic effects in rats elicited by 3-nitropropionic acid in acute and subacute administration. | Environmental toxicology and pharmacology 20050501 |
| Susceptibility to excitotoxic and metabolic striatal neurodegeneration in the mouse is genotype dependent. | Brain research 20050408 |
| Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation. | Journal of neural transmission (Vienna, Austria : 1996) 20050401 |
| Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats. | Neuropharmacology 20050401 |
| Toxicity and metabolism of the conjugates of 3-nitropropanol and 3-nitropropionic acid in forages poisonous to livestock. | Journal of agricultural and food chemistry 20050323 |
| Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. | The American journal of pathology 20050301 |
| Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. | Brain research 20050221 |
| 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. | Brain research. Molecular brain research 20050218 |
| Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. | Brain research. Molecular brain research 20050218 |
| Minocycline in phenotypic models of Huntington's disease. | Neurobiology of disease 20050201 |
| Acute effects of pulsed microwaves and 3-nitropropionic acid on neuronal ultrastructure in the rat caudate-putamen. | Bioelectromagnetics 20050201 |
| Paradoxical increase in 3-nitropropionic acid neurotoxicity by alpha-phenyl-tert-butyl-nitrone, a spin-trapping agent. | Chang Gung medical journal 20050201 |
| Scope and limitations of the nitro-Mannich reaction for the stereoselective synthesis of 1,2-diamines. | The Journal of organic chemistry 20050121 |
| 3-nitropropionic acid model of metabolic stress: assessment by magnetic resonance imaging. | Methods in molecular medicine 20050101 |
| Adenosine A1 receptors and the anticonvulsant potential of drugs effective in the model of 3-nitropropionic acid-induced seizures in mice. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050101 |
| A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities. | Experimental neurology 20050101 |
| Neurotrophic factor expression after focal brain ischemia preceded by different preconditioning strategies. | Cerebrovascular diseases (Basel, Switzerland) 20050101 |
| Permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by degeneration of the lateral wall of the cochlea. | Audiology & neuro-otology 20050101 |
| Gait dynamics in mouse models of Parkinson's disease and Huntington's disease. | Journal of neuroengineering and rehabilitation 20050101 |
| Overexpression of Bcl-xl protects septal neurons from prolonged hypoglycemia and from acute ischemia-like stress. | Neuroscience 20050101 |
| Chemical preconditioning by 3-nitropropionic acid reduces ischemia-reperfusion injury in rat heart. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20050101 |
| FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures. | Neurobiology of disease 20041201 |
| Nicotinic receptor modulation for neuroprotection and enhancement of functional recovery following brain injury or disease. | Annals of the New York Academy of Sciences 20041201 |
| Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes. | European journal of pharmacology 20041119 |
| The mitochondrial toxin, 3-nitropropionic acid, induces extracellular Zn2+ accumulation in rat hippocampus slices. | Neuroscience letters 20041111 |
| A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. | Neurobiology of disease 20041101 |
| Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. | Journal of pineal research 20041101 |
| Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo. | Neuroreport 20041025 |
| Creatine protects against 3-nitropropionic acid-induced cell death in murine corticostriatal slice cultures. | Brain research 20041022 |
| Menadione reduces rotenone-induced cell death in cerebellar granule neurons. | Neuroreport 20041005 |
| Influence of chemical and ischemic preconditioning on cytokine expression after focal brain ischemia. | Journal of neuroscience research 20041001 |
| Increased Alix (apoptosis-linked gene-2 interacting protein X) immunoreactivity in the degenerating striatum of rats chronically treated by 3-nitropropionic acid. | Neuroscience letters 20040930 |
| Neuroprotective effect of L-carnitine in the 3-nitropropionic acid (3-NPA)-evoked neurotoxicity in rats. | Neuroscience letters 20040902 |
| Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition. | Journal of neurochemistry 20040901 |
| Antioxidant effects of taurine, vitamin C, and vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats. | The International journal of neuroscience 20040901 |
| Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. | The Journal of biological chemistry 20040813 |
| The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism. | Journal of neurochemistry 20040801 |
| Strain dependence of receptor regulation on chemical preconditioning in mice hippocampus. | Neuroscience letters 20040729 |
| A novel animal model of acute cochlear mitochondrial dysfunction. | Neuroreport 20040719 |
| Nitrification by plants that also fix nitrogen. | Nature 20040701 |
| Altered oxidative stress response of the long-lived Snell dwarf mouse. | Biochemical and biophysical research communications 20040611 |
| 3-Nitropropionic acid-induced neurotoxicity--assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy. | Journal of neurochemistry 20040601 |
| Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. | Neurobiology of disease 20040601 |
| Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. | The European journal of neuroscience 20040601 |
| Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. | Neuroscience letters 20040527 |
| Induction of corticostriatal LTP by 3-nitropropionic acid requires the activation of mGluR1/PKC pathway. | Neuropharmacology 20040501 |
| Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. | Human molecular genetics 20040401 |
| Production of toxic metabolites in Aspergillus niger, Aspergillus oryzae, and Trichoderma reesei: justification of mycotoxin testing in food grade enzyme preparations derived from the three fungi. | Regulatory toxicology and pharmacology : RTP 20040401 |
| Experimental basis for the putative role of GluR6/kainate glutamate receptor subunit in Huntington's disease natural history. | Neurobiology of disease 20040401 |
| Effect of glucocorticoids on 3-nitropropionic acid-induced oxidative stress in synaptosomes. | European journal of pharmacology 20040319 |
| Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease. | Neurobiology of disease 20040301 |
| Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. | Journal of neurochemistry 20040301 |
| Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. | Journal of neurochemistry 20040301 |
| Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. | Journal of neurochemistry 20040201 |
| Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms. | Neurobiology of disease 20040201 |
| Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. | Progress in neurobiology 20040201 |
| Chronic intoxication with 3-nitropropionic acid in rats induces the loss of striatal dopamine terminals without affecting nigral cell viability. | Neuroscience letters 20040116 |
| MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: reference to striatonigral degeneration. | Experimental neurology 20040101 |
| Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. | Molecular and cellular neurosciences 20040101 |
| Sertoli cell grafts for Huntington's disease. An opinion. | Neurotoxicity research 20040101 |
| Chronic memantine does not block 3-nitropropionic acid-delayed ischaemic tolerance in rat hippocampal slices ex vivo. | Neurotoxicity research 20040101 |
| Involvement of apoptosis in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20040101 |
| Differential depression of spinal synaptic transmission in vitro by different hypoxic insults. | Indian journal of experimental biology 20040101 |
| Pharmacological preconditioning in global cerebral ischemia. | Acta neurochirurgica. Supplement 20040101 |
| Hypoxic increase in nitric oxide generation of rat sensory neurons requires activation of mitochondrial complex II and voltage-gated calcium channels. | Neuroscience 20040101 |
| Inhibition of caspase-3 activation and apoptosis is involved in 3-nitropropionic acid-induced ischemic tolerance to transient focal cerebral ischemia in rats. | Journal of molecular neuroscience : MN 20040101 |
| Neurotoxins and neurotoxic species implicated in neurodegeneration. | Neurotoxicity research 20040101 |
| Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. | Brain research 20031219 |
| Glutamate uptake inhibitor L-trans-pyrrolidine 2,4-dicarboxylate becomes neurotoxic in the presence of subthreshold concentrations of mitochondrial toxin 3-nitropropionate: involvement of mitochondrial reducing activity and ATP production. | Journal of neuroscience research 20031215 |
| Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungs. | American journal of respiratory cell and molecular biology 20031201 |
| Bcl-2 prevents loss of cell viability and caspase activation induced by 3-nitropropionic acid in GT1-7 cells. | Annals of the New York Academy of Sciences 20031201 |
| Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. | Journal of neurochemistry 20031101 |
| In vivo calpain/caspase cross-talk during 3-nitropropionic acid-induced striatal degeneration: implication of a calpain-mediated cleavage of active caspase-3. | The Journal of biological chemistry 20031031 |
| 3-Nitropropionic acid increases frataxin expression in human lymphoblasts and in transgenic rat PC12 cells. | Neuroscience letters 20031030 |
| Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20031015 |
| Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. | Experimental neurology 20031001 |
| Neurodegeneration in striatum induced by the mitochondrial toxin 3-nitropropionic acid: role of matrix metalloproteinase-9 in early blood-brain barrier disruption? | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030924 |
| Chemical preconditioning prevents paradoxical increase in glutamate release during ischemia by activating ATP-dependent potassium channels in gerbil hippocampus. | Experimental neurology 20030901 |
| Type I glutaric aciduria, part 2: a model of acute striatal necrosis. | American journal of medical genetics. Part C, Seminars in medical genetics 20030815 |
| Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy). | Acta neuropathologica 20030801 |
| Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington's disease. | The European journal of neuroscience 20030801 |
| Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid. | Neurochemistry international 20030701 |
| Alpha-synuclein protects naive but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. | Journal of neurochemistry 20030701 |
| GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. | The Journal of comparative neurology 20030630 |
| Calpain is a major cell death effector in selective striatal degeneration induced in vivo by 3-nitropropionate: implications for Huntington's disease. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030615 |
| A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030615 |
| The effect on motor cortical neuronal development of focal lesions to the sub-cortical white matter in the neonatal rat: a model for periventricular leukomalacia. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20030601 |
| Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. | Experimental neurology 20030601 |
| 1,3-Dinitrobenzene inhibits mitochondrial complex II in rat and mouse brainstem and cortical astrocytes. | Neurotoxicology 20030601 |
| Age-associated changes in SAPK/JNK and p38 MAPK signaling in response to the generation of ROS by 3-nitropropionic acid. | Mechanisms of ageing and development 20030601 |
| Calpain facilitates the neuron death induced by 3-nitropropionic acid and contributes to the necrotic morphology. | Journal of neuropathology and experimental neurology 20030601 |
| Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. | American journal of physiology. Lung cellular and molecular physiology 20030501 |
| Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030501 |
| Possible mechanism for the neuroprotective effects of L-carnitine on methamphetamine-evoked neurotoxicity. | Annals of the New York Academy of Sciences 20030501 |
| Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction. | Annals of the New York Academy of Sciences 20030501 |
| 3-nitropropionic acid inhibition of succinate dehydrogenase (complex II) activity in cultured Chinese hamster ovary cells: antagonism by L-carnitine. | Annals of the New York Academy of Sciences 20030501 |
| Opening of mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. | Stroke 20030401 |
| Quantitative on-line monitoring of hippocampus glucose and lactate metabolism in organotypic cultures using biosensor technology. | Journal of neurochemistry 20030401 |
| Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage. | Experimental neurology 20030401 |
| Knockout of p75NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury. | Journal of molecular neuroscience : MN 20030401 |
| Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid. | Journal of neuroscience research 20030315 |
| Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. | Human molecular genetics 20030301 |
| Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. | Journal of neurochemistry 20030301 |
| Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies. | Neurobiology of disease 20030301 |
| Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices. | Experimental neurology 20030101 |
| Polycyclic phenols, estrogens and neuroprotection: a proposed mitochondrial mechanism. | Experimental gerontology 20030101 |
| Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. | Neurotoxicity research 20030101 |
| FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices. | Acta neurobiologiae experimentalis 20030101 |
| Mitochondrial complex II is essential for hypoxia-induced ROS generation and vasoconstriction in the pulmonary vasculature. | Advances in experimental medicine and biology 20030101 |
| Mitochondrial complex I inhibition produces selective damage to hippocampal subfield CA1 in organotypic slice cultures. | Neurotoxicity research 20030101 |
| Effects of Sertoli cell transplants in a 3-nitropropionic acid model of early Huntington's disease: a preliminary study. | Neurotoxicity research 20030101 |
| Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine+3-nitropropionic acid model of striatonigral degeneration in monkeys. | Neuroscience letters 20021219 |
| Estrogen blocks 3-nitropropionic acid-induced Ca2+i increase and cell damage in cultured rat cerebral endothelial cells. | Brain research 20021122 |
| Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. | The Journal of biological chemistry 20021018 |
| The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20021015 |
| 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. | Neuroscience letters 20020913 |
| Analysis of mitochondrial free radical generation in animal models of neuronal disease. | Free radical biology & medicine 20020901 |
| The effect of aging on p38 signaling pathway activity in the mouse liver and in response to ROS generated by 3-nitropropionic acid. | Mechanisms of ageing and development 20020901 |
| Effect of 3-nitropropionic acid on kynurenine aminotransferase in the rat brain. | Experimental neurology 20020901 |
| 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures. | Neuroscience letters 20020823 |
| Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020801 |
| Striatal and cortical neurochemical changes induced by chronic metabolic compromise in the 3-nitropropionic model of Huntington's disease. | Neurobiology of disease 20020801 |
| Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-[13C] NMR spectroscopy. | Journal of neurochemistry 20020801 |
| Reduction of Alamar Blue, a novel redox indicator, is dependent on both the glycolytic and oxidative metabolism of glucose in rat cultured neurons. | Neuroscience letters 20020705 |
| The differential vulnerability of striatal projection neurons in 3-nitropropionic acid-treated rats does not match that typical of adult-onset Huntington's disease. | Experimental neurology 20020701 |
| beta-Amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals: implications for Alzheimer's disease. | Experimental neurology 20020701 |
| 3-Nitropropionic acid neurotoxicity in hippocampal slice cultures: developmental and regional vulnerability and dependency on glucose. | Experimental neurology 20020701 |
| Mice overexpressing 70-kDa heat shock protein show increased resistance to malonate and 3-nitropropionic acid. | Experimental neurology 20020701 |
| Involvement of superoxide in excitotoxicity and DNA fragmentation in striatal vulnerability in mice after treatment with the mitochondrial toxin, 3-nitropropionic acid. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020701 |
| Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020601 |
| Dopamine transporter knock-out mice are hypersensitive to 3-nitropropionic acid-induced striatal damage. | The European journal of neuroscience 20020601 |
| A method to assay glyoxylate cycle inhibitors for antifungals. | The Journal of antibiotics 20020601 |
| 3-nitropropionic acid-induced changes in bilayer fluidity in synaptosomal membranes: implications for Huntington's disease. | Neurochemical research 20020601 |
| Chemical preconditioning with 3-nitropropionic acid: lack of induction of neuronal tolerance in gerbil hippocampus subjected to transient forebrain ischemia. | Brain research bulletin 20020501 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. | Biochemical pharmacology 20020415 |
| Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease. | Synapse (New York, N.Y.) 20020401 |
| Gender-dependent hypoxic tolerance mediated via gender-specific mechanisms. | Journal of neuroscience research 20020401 |
| [Huntington disease]. | Nihon rinsho. Japanese journal of clinical medicine 20020401 |
| Coenzyme Q10 as a possible treatment for neurodegenerative diseases. | Free radical research 20020401 |
| Evaluation of 3-nitrotyrosine as a marker for 3-nitropropionic acid-induced oxidative stress in Lewis and Wistar rats and strain-specific whole brain spheroid cultures. | Brain research 20020322 |
| Excitotoxic and metabolic damage to the rodent striatum: role of the P75 neurotrophin receptor and glial progenitors. | The Journal of comparative neurology 20020318 |
| The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20020315 |
| Modulation of apoptotic regulatory proteins and early activation of cytochrome C following systemic 3-nitropropionic acid administration. | Brain research bulletin 20020315 |
| ATP-dependent potassium channel mediates neuroprotection by chemical preconditioning with 3-nitropropionic acid in gerbil hippocampus. | Neuroscience letters 20020301 |
| Hypoxic tolerance induction in rat brain slices following 3-nitropropionic acid pretreatment as revealed by dynamic changes in glucose metabolism. | Neuroscience letters 20020215 |
| Immediate-early gene response to methamphetamine, haloperidol, and quinolinic acid is not impaired in Huntington's disease transgenic mice. | Journal of neuroscience research 20020201 |
| The mitochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20020201 |
| Partial ablations of the flocculus and ventral paraflocculus in monkeys cause linked deficits in smooth pursuit eye movements and adaptive modification of the VOR. | Journal of neurophysiology 20020201 |
| Evaluation of neuronal cell death by laser scanning cytometry. | Brain research. Brain research protocols 20020201 |
| A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. | Journal of neuroscience methods 20020130 |
| Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. | Neurosurgery 20020101 |
| The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. | Neuroscience 20020101 |
| Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons. | Neuroscience 20020101 |
| Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice. | Neuroscience 20020101 |
| Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation. | Neuroscience 20020101 |
| Increased neuronal hypoxic tolerance induced by repetitive chemical hypoxia. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20020101 |
| Neuroprotective role of L-carnitine in the 3-nitropropionic acid induced neurotoxicity. | Toxicology letters 20011215 |
| Elucidation of the quantitative significance of pyruvate carboxylation in cultured cerebellar neurons and astrocytes. | Journal of neuroscience research 20011201 |
| Excretion of miserotoxin and detoxification of the aglycone by grasshoppers (Orthoptera: Acrididae). | Phytochemistry 20011101 |
| Perseverative behavior underlying attentional set-shifting deficits in rats chronically treated with the neurotoxin 3-nitropropionic acid. | Experimental neurology 20011101 |
| Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic acid in vitro. | Experimental neurology 20011101 |
| Concentrations of different sterols in the striatum and serum of 3-nitropropionic acid-treated Wistar and Lewis rats. | Neurochemical research 20011101 |
| A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. | Experimental neurology 20011001 |
| Mitochondrial toxin 3-nitropropionic acid induces cardiac and neurotoxicity differentially in mice. | The American journal of pathology 20011001 |
| Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. | Brain research. Brain research protocols 20011001 |
| Phospholipid fatty acids and neurotoxicity in human neuroblastoma SH-SY5Y cells. | Neuroscience letters 20010831 |
| In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. | Neuroreport 20010828 |
| Taurine increases rat survival and reduces striatal damage caused by 3-nitropropionic acid. | The International journal of neuroscience 20010801 |
| Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease. | Neuroreport 20010720 |
| Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010715 |
| Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat. | Neuroreport 20010613 |
| Protective effect of adenosine receptor agonists in a new model of epilepsy--seizures evoked by mitochondrial toxin, 3-nitropropionic acid, in mice. | Neuroscience letters 20010608 |
| Effect of L-carnitine pretreatment on 3-nitropropionic acid-induced inhibition of rat brain succinate dehydrogenase activity. | Annals of the New York Academy of Sciences 20010601 |
| Biomarkers of 3-nitropropionic acid (3-NPA)-induced mitochondrial dysfunction as indicators of neuroprotection. | Annals of the New York Academy of Sciences 20010601 |
| Strategies for neuroprotection against L-trans-2,4-pyrrolidine dicarboxylate-induced neuronal damage during energy impairment in vitro. | Journal of neuroscience research 20010515 |
| Manganese toxicity is associated with mitochondrial dysfunction and DNA fragmentation in rat primary striatal neurons. | Brain research bulletin 20010515 |
| Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial K(ATP) channel. | American journal of physiology. Heart and circulatory physiology 20010501 |
| Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. | Journal of neurochemistry 20010501 |
| Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid. | Experimental neurology 20010401 |
| N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. | Journal of neurochemistry 20010401 |
| Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. | Neurochemistry international 20010301 |
| [Neuroprotective effect of a neurotoxin, 3-nitropropionic acid, against hypoxic damage to the gerbil hippocampus: neuroprotection after the onset of hypoxic depolarization]. | No to shinkei = Brain and nerve 20010301 |
| Contamination of food with mycotoxins and human health. | Arhiv za higijenu rada i toksikologiju 20010301 |
| White matter damage following systemic injection of the mitochondrial inhibitor 3-nitropropionic acid in rat. | Brain research 20010223 |
| Chemical preconditioning in mice is not mediated by upregulation of nitric oxide synthase isoforms. | Neuroscience letters 20010216 |
| 'Chemical preconditioning' by 3-nitropropionate reduces ischemia-reperfusion injury in cardiac-arrested rat lungs. | Transplantation 20010215 |
| Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. | British journal of pharmacology 20010201 |
| Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. | Neurobiology of disease 20010201 |
| The mitochondrial toxin 3-nitropropionic acid induces differential expression patterns of apoptosis-related markers in rat striatum. | Neuropathology and applied neurobiology 20010201 |
| Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20010101 |
| Mice with a partial deficiency of manganese superoxide dismutase show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic acid, and MPTP. | Experimental neurology 20010101 |
| On the mechanisms of neuroprotection by creatine and phosphocreatine. | Journal of neurochemistry 20010101 |
| No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy). | Neuroscience 20010101 |
| Behavioural correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. | Neuroscience 20010101 |
| Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates. | Neuroscience 20010101 |
| Neuronal ectopic expression of tyrosine hydroxylase in the mouse striatum by combined administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 3-nitropropionic acid. | Neuroscience 20010101 |
| Neurotoxicology of the brain barrier system: new implications. | Journal of toxicology. Clinical toxicology 20010101 |
| Effect of adenosine receptor agonists on neurodegenerative and convulsive activity of mitochondrial toxin, 3-nitropropionic acid. | Polish journal of pharmacology 20010101 |
| Brain tolerance and preconditioning. | Polish journal of pharmacology 20010101 |
| Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. | Journal of neurochemistry 20001201 |
| Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease. | Journal of molecular neuroscience : MN 20000801 |
| Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. | Annals of tropical medicine and parasitology 19961201 |
| [Studies on the potentiation of the antibiotics contained in Prednobiotad]. | DTW. Deutsche tierarztliche Wochenschrift 19760105 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.